NASDAQ:WVEWave Life Sciences Stock Price, Forecast & News

Wave Life Sciences' stock was trading at $8.12 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, WVE stock has increased by 22.0% and is now trading at $9.91. View which stocks have been most impacted by Coronavirus.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Wave Life Sciences in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Wave Life Sciences.

Wave Life Sciences is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Wave Life Sciences.

Wave Life Sciences Ltd (NASDAQ:WVE) announced its earnings results on Monday, May, 11th. The company reported ($1.38) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.34) by $0.04. The business earned $4.16 million during the quarter, compared to analyst estimates of $7.26 million. Wave Life Sciences had a negative return on equity of 219.06% and a negative net margin of 1,150.43%. View Wave Life Sciences' earnings history.

6 equities research analysts have issued 1-year price targets for Wave Life Sciences' shares. Their forecasts range from $10.00 to $25.00. On average, they expect Wave Life Sciences' share price to reach $19.20 in the next year. This suggests a possible upside of 93.7% from the stock's current price. View analysts' price targets for Wave Life Sciences.

Media stories about WVE stock have been trending negative this week, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Wave Life Sciences earned a media sentiment score of -2.2 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 5.0 out of 10, meaning that recent media coverage is somewhat likely to have an effect on the stock's share price in the immediate future. View the latest news about Wave Life Sciences.

Wave Life Sciences saw a increase in short interest in June. As of June 30th, there was short interest totaling 5,010,000 shares, an increase of 6.8% from the June 15th total of 4,690,000 shares. Based on an average trading volume of 506,900 shares, the short-interest ratio is presently 9.9 days. Approximately 17.6% of the shares of the company are short sold. View Wave Life Sciences' Current Options Chain.

Some companies that are related to Wave Life Sciences include Portola Pharmaceuticals (PTLA), Kiniksa Pharmaceuticals (KNSA), Heron Therapeutics (HRTX), Esperion Therapeutics (ESPR), Amneal Pharmaceuticals (AMRX), Arvinas (ARVN), Tricida (TCDA), Theravance Biopharma (TBPH), Odonate Therapeutics (ODT), Rocket Pharmaceuticals (RCKT), Supernus Pharmaceuticals (SUPN), I-Mab (ARQT), Constellation Pharmaceuticals (CNST), DiaMedica Therapeutics (DMCAF) and Athenex (ATNX). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Wave Life Sciences investors own include Gilead Sciences (GILD), Crispr Therapeutics (CRSP), Exelixis (EXEL), Novavax (NVAX), Sangamo Therapeutics (SGMO), Sorrento Therapeutics (SRNE), Aduro BioTech (ADRO), Micron Technology (MU), AT&T (T) and TherapeuticsMD (TXMD).

Wave Life Sciences trades on the NASDAQ under the ticker symbol "WVE."

Shares of WVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of WVE stock can currently be purchased for approximately $9.91.

Wave Life Sciences has a market capitalization of $354.08 million and generates $15.98 million in revenue each year. The company earns $-193,640,000.00 in net income (profit) each year or ($5.72) on an earnings per share basis. Wave Life Sciences employs 250 workers across the globe.

The official website for Wave Life Sciences is www.wavelifesciences.com.

Wave Life Sciences' mailing address is 7 STRAITS VIEW #12-00 MARINA ONE EAST TOWER, SINGAPORE U0, 018936. The company can be reached via phone at 65-6236-3388 or via email at [email protected]